Top Story
Vaccine cure for RA heads to human trial
A team of scientists at Newcastle University is preparing a small human trial to test a one-shot approach to curing rheumatoid arthritis with a vaccine devised from a patient's white blood cells. The cells are taken from the volunteers and manipulated with a recipe of chemicals, steroids and Vitamin D so they can suppress the immune system rather than spur it. And a single jab could be enough to suppress the auto-immune response that triggers rheumatoid arthritis. Report
Report
Vaccine may offer protection from black plague
An experimental vaccine created from genetically engineered plant cells appears to be effective against the Black Plague, which has bedeviled the world for centuries and is listed as a top bioterror threat. And because they've developed an oral version of the vaccine, researchers at the University of Central Florida say they can produce mass quantities at a low cost. Report
From the Network
Press Releases
- PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
- RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
- TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
- Galapagos acquires structure-based drug discovery from Sareum
- Manhattan Research Announces Top 10 Product Sites Visited by Physicians
Latest Comments
Editors
About FierceVaccines
FierceVaccines gives industry insiders the latest vaccine industry news and developments. Our FREE weekly email newsletter covers the people, trends, and research projects shaping the vaccine market.
© FierceMarkets, Inc.
® All rights reserved
1319 F St NW, 6th Floor
Washington, D.C. 20004
+1.202.628.8778
www.fiercemarkets.com
Latest News
Pfizer teams with Cytos to develop new vaccines
Further bolstering its ambitious vaccine program, Pfizer has teamed up with Cytos Biotechnology to develop, manufacture and commercialize vaccines for a defined number of human diseases. Cytos gains Read more...
1918 flu survivors' blood may hold key to better vax
Scientists were able to identify the antibodies that still circulate in the blood of survivors of the deadly 1918 flu outbreak and found that they still proved to be a potent antidote to the disease. Read more...
Critics accuse Merck of hyping cervical cancer risk
Just how important Gardasil has become to Merck's top line is underscored by a New York Times article analyzing the impact of what the pharma company calls "educational programs" and just about Read more...
Study examines cost-effectiveness of Gardasil
A new study in the New England Journal of Medicine questions the cost-effectiveness of Gardasil in older women, saying that the payback is reduced by their increased exposure to the virus that causes Read more...
Nanotech hep B vaccine could revolutionize therapy
Scientists at the University of Michigan are moving closer to human trials of a new nanoemulsion hepatitis B vaccine that could revolutionize therapy in the third world. The nanoemulsion approach Read more...
Other pandemic threats are lurking in H9 virus
H5N1 isn't the only avian virus that threatens to trigger a pandemic. A group of virologists was able to make an H9 virus much more transmissible by changing a single chemical component in the Read more...
Woman's immune system may be key to HIV vax
An investigative team at Johns Hopkins has been studying a woman whose natural immunity has quelled the virus she was infected with 10 years ago. Researchers say that she is an 'elite suppressor:' Read more...
Researchers post positive late-stage Heplisav data
Researchers for Dynavax and Merck say that a late-stage trial of their hepatitis B vaccine Heplisav hit the endpoint they were aiming at: non-inferior antibody response compared to GlaxoSmithKline's Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets